-
Epinephrine in Local Anesthesia: Key Findings
2026-10-01
The 1986 review by Cassidy, Phero, and Grau examines how vasoconstrictors alter local-anesthetic performance and systemic physiology, with particular emphasis on epinephrine concentration. Its central practical conclusion is that 1:200,000 epinephrine can often provide effective anesthesia while limiting avoidable cardiovascular stimulation, although dose, injection technique, and patient factors remain decisive.
-
FOXM1–ERα Network in Female Lung Adenocarcinoma
2026-10-01
This reference study combines public transcriptomic datasets, survival and immune analyses, ceRNA modeling, and cellular validation to investigate FOXM1 in female lung adenocarcinoma. Its central contribution is a proposed FOXM1–miR-204-5p–ERα regulatory axis, while the incomplete validation of the DGCR5 component highlights important limits for mechanistic interpretation.
-
TPCA-1 in Septic AKI: Assay Logic for NF-κB
2026-09-30
TPCA-1 is a selective IKK-2 inhibitor for testing how NF-κB signaling connects inflammation with tubular injury in septic AKI. This article translates recent NF-κB/Apaf1/caspase-9 findings into a causal assay strategy while distinguishing mechanistic evidence from therapeutic claims.
-
Nifedipine Workflows for Calcium and Liver Studies
2026-09-30
Nifedipine (BAY-a-1040) offers a practical L-type calcium channel perturbation strategy for studying calcium-dependent signaling, iron transport, contraction, and microbial development. This guide shows how to pair calcium influx inhibition with orthogonal CYP and PXR measurements without confusing a mechanistic comparator with a PXR activator.
-
Salvianolic Acid B: A Mechanistic Fibrosis Playbook
2026-09-29
Salvianolic acid B, also known as Dan Shen Suan B, is emerging as a mechanistically defined natural product for fibrosis studies. By linking LH2/PLOD2 expression with collagen cross-linking, epithelial and fibroblast state changes, and extracellular matrix remodeling, it offers translational researchers a stronger framework than single-endpoint antifibrotic screening.
-
Naloxone Hydrochloride: From Reversal to Translation
2026-09-29
Naloxone hydrochloride is best understood as a translational research tool that connects opioid receptor pharmacology with neural stem cell biology, immune modulation, and behavioral neuroscience. This article outlines how to separate receptor-dependent effects from TET1-associated activity, build stronger validation workflows, and apply disciplined translational standards inspired by modern drug-discovery research.
-
Panobinostat (LBH589): Mechanism and Research Use
2026-09-28
Panobinostat (LBH589) is a broad-spectrum HDAC inhibitor used to investigate histone acetylation, cancer-cell responses, and drug resistance. The product information reports low-nanomolar cellular IC₅₀ values in two leukemia cell lines, while interpretation requires distinguishing growth inhibition from cell killing.
-
BRD4770: A G9a Histone Methyltransferase Inhibitor
2026-09-27
BRD4770 gives cancer researchers a way to test whether G9a-dependent H3K9 methylation contributes to tumor-cell fitness and senescence. This workflow pairs careful formulation checks with early epigenetic readouts and later proliferation assays, while keeping breast-cancer pathway findings distinct from evidence in PANC-1 cells.
-
EGTA for Reliable Calcium-Linked Viability Assays
2026-09-26
Learn how EGTA (SKU B7195) can help test whether extracellular calcium contributes to cell injury or viability changes, while avoiding common solubility and interpretation pitfalls. The guide separates product specifications from published calcium-channel findings and offers practical steps for controlled assay design.
-
Polyphyllin H Reverses Paclitaxel Resistance
2026-09-26
A 2025 study reports that Polyphyllin H binds membrane cholesterol, disrupts cholesterol-rich lipid rafts, and suppresses the drug-efflux transporters ABCB1 and ABCC3 in paclitaxel-resistant breast cancer models. The findings suggest a multi-transporter resistance strategy, while further work is needed to establish its safety and relevance in patients.
-
DNase I (RNase-free) for Clean RNA Workflows
2026-09-25
Remove DNA without sacrificing RNA quality in extraction, RT-PCR, and in vitro transcription workflows. Practical controls connect this sample-preparation step to a human sensory-neuron study while keeping the distinction clear: DNase cleanup supports molecular assays, not electrophysiology itself.
-
Rice Stripe Virus NS3 Rewires Host Kinase Signaling
2026-09-25
Zhuang et al. show that RSV NS3 shifts between distinct, infection-stage-dependent effects on rice kinase signaling, shaping antiviral defense, pathogenicity, and transmission. The work links NS3 phosphorylation and host ROS signaling to a proposed virus–plant–vector co-survival strategy, while highlighting the need to distinguish findings in plant virology from kinase studies in other systems.
-
Perifosine (KRX-0401): Assays and Workflows
2026-09-24
Perifosine offers a practical way to perturb Akt signaling in cancer-cell viability, apoptosis, and radiation-response experiments. This guide turns its reported activity into a controlled workflow—and distinguishes those oncology applications from the very different, early-stage stroke findings involving Akt/mTOR signaling.
-
Salvianolic Acid B, LH2, and Pulmonary Fibrosis
2026-09-24
The reference study connects elevated lysyl hydroxylase 2 (LH2) with collagen remodeling in pulmonary fibrosis and reports that Salvianolic acid B reduces LH2 expression alongside fibrotic features. Its value is a mechanism-led framework for testing collagen cross-linking, epithelial and fibroblast state changes, and Wnt/β-catenin signaling—not proof that the compound directly binds LH2 or is an established treatment.
-
SB525334 Workflows for TGF-beta1 Signaling
2026-09-23
Learn how to use SB525334 to isolate ALK5-dependent TGF-beta signaling in fibrosis, renal disease, and wound-healing assays. This practical guide connects Smad2/3 phosphorylation inhibition with the bone-transport findings reported in diabetic foot ulcer research.